Progress towards the prevention and treatment of norovirus infections

Armando Arias, Edward Emmott, Surender Vashist, Ian Goodfellow

Research output: Contribution to journalJournal articleResearchpeer-review

36 Downloads (Pure)


Noroviruses are now recognized as the major cause of acute gastroenteritis in the developed world, yet our ability to prevent and control infection is limited. Recent work has highlighted that, while typically an acute infection in the population, immunocompromised patients often experience long-term infections that may last many years. This cohort of patients and those regularly exposed to infectious material, for example, care workers and others, would benefit greatly from the development of a vaccine or antiviral therapy. While a licensed vaccine or antiviral has yet to be developed, work over the past 10 years in this area has intensified and trials with a vaccine candidate have proven promising. Numerous antiviral targets and small molecule inhibitors that have efficacy in cell culture have now been identified; however, further studies in this area are required in order to make these suitable for clinical use.
Original languageEnglish
JournalFuture Microbiology
Issue number11
Pages (from-to)1475-1487
Publication statusPublished - 2013
Externally publishedYes

Bibliographical note

This article is distributed under the terms of the Creative Commons Attribution License 3.0

Fingerprint Dive into the research topics of 'Progress towards the prevention and treatment of norovirus infections'. Together they form a unique fingerprint.

Cite this